1. Home
  2. EXAS vs ARMK Comparison

EXAS vs ARMK Comparison

Compare EXAS & ARMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • ARMK
  • Stock Information
  • Founded
  • EXAS 1995
  • ARMK 1959
  • Country
  • EXAS United States
  • ARMK United States
  • Employees
  • EXAS N/A
  • ARMK N/A
  • Industry
  • EXAS Medical Specialities
  • ARMK Restaurants
  • Sector
  • EXAS Health Care
  • ARMK Consumer Discretionary
  • Exchange
  • EXAS Nasdaq
  • ARMK Nasdaq
  • Market Cap
  • EXAS 12.3B
  • ARMK 9.6B
  • IPO Year
  • EXAS N/A
  • ARMK 2013
  • Fundamental
  • Price
  • EXAS $71.05
  • ARMK $38.23
  • Analyst Decision
  • EXAS Strong Buy
  • ARMK Strong Buy
  • Analyst Count
  • EXAS 13
  • ARMK 12
  • Target Price
  • EXAS $79.00
  • ARMK $39.38
  • AVG Volume (30 Days)
  • EXAS 1.4M
  • ARMK 1.7M
  • Earning Date
  • EXAS 11-05-2024
  • ARMK 11-11-2024
  • Dividend Yield
  • EXAS N/A
  • ARMK 0.99%
  • EPS Growth
  • EXAS N/A
  • ARMK N/A
  • EPS
  • EXAS N/A
  • ARMK 1.31
  • Revenue
  • EXAS $2,612,011,000.00
  • ARMK $19,954,685,000.00
  • Revenue This Year
  • EXAS $15.53
  • ARMK N/A
  • Revenue Next Year
  • EXAS $13.78
  • ARMK $6.24
  • P/E Ratio
  • EXAS N/A
  • ARMK $29.10
  • Revenue Growth
  • EXAS 13.54
  • ARMK 22.62
  • 52 Week Low
  • EXAS $40.62
  • ARMK $25.93
  • 52 Week High
  • EXAS $79.62
  • ARMK $39.99
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 55.81
  • ARMK 51.61
  • Support Level
  • EXAS $68.61
  • ARMK $37.80
  • Resistance Level
  • EXAS $71.49
  • ARMK $38.52
  • Average True Range (ATR)
  • EXAS 1.91
  • ARMK 0.65
  • MACD
  • EXAS -0.34
  • ARMK -0.14
  • Stochastic Oscillator
  • EXAS 50.41
  • ARMK 33.47

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.

About ARMK Aramark

Aramark provides food, facilities, and uniform services to a variety of clients and institutions. The majority of company revenue comes from its North American food and support services segment. Smaller but substantial segments include food and support services international, food and support services united states and uniform and career apparel. The food and support services segments provide food for school districts; colleges; healthcare facilities; correctional institutions; and business, sports, and entertainment venues. The uniform segment rents, delivers, cleans, and maintains work clothes and ancillary items like towels and mats to customers in North America and Japan. The company has hundreds of service locations and distribution centers across the United States and Canada.

Share on Social Networks: